Information Provided By:
Fly News Breaks for August 9, 2018
CVS
Aug 9, 2018 | 09:10 EDT
Leerink analyst David Larsen lowered his price target for CVS Health to $80 from $85 as he remains disappointed by the 2018 Retail margin guide. Nonetheless, the analyst is encouraged by CVS' good performance this quarter and increased FY18 guidance, and by the impressive growth in Retail SS Rx volumes. Larsen reiterates an Outperform rating on the shares.
News For CVS From the Last 2 Days
CVS
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.